SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-002353
Filing Date
2018-01-31
Accepted
2018-01-31 11:08:22
Documents
1
Period of Report
2018-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3162
  Complete submission text file 0000899243-18-002353.txt   5627
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Reporting) CIK: 0000019617 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38360 | Film No.: 18561500
SIC: 6021 National Commercial Banks

Mailing Address 161 FIRST STREET, THIRD FLOOR CAMBRIDGE MA 02142
Business Address 161 FIRST STREET, THIRD FLOOR CAMBRIDGE MA 02142 617-337-4682
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVENUE NEW YORK NY 10017 212-270-6000
JPMC Strategic Investments II Corp (Reporting) CIK: 0001728848 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38360 | Film No.: 18561499